Brief: Ovid Therapeutics Reports First Quarter 2022 Financial Results

Ovid Therapeutics

10/05/2022 13:08

May 10 (Reuters) - Ovid Therapeutics Inc  OVID.O :
    * OVID THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND CORPORATE HIGHLIGHTS
    * Q1 LOSS PER SHARE $0.23
    * Q1 REVENUE $1.4 MILLION
    * OVID THERAPEUTICS - SEES MULTI-YEAR CASH AND CASH
EQUIVALENTS TO
SUPPORT PROGRESSION OF CURRENT PIPELINE OF DIFFERENTIATED
EPILEPSY PROGRAMS INTO 2025
    * Q1 EARNINGS PER SHARE VIEW $-0.21, REVENUE VIEW $0.00 --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6b7StS 
Further company coverage:  OVID.O 

 ((Reuters.Briefs@thomsonreuters.com;))